INSM
INSMED Inc
NASDAQ · Healthcare · Biotechnology · US
$96.27
−2.96%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$99.02
From 52W high−54.46%
Volume2.40M
Market cap$21.02B
P/E (TTM)—
P/S (TTM)18.5x
Div yield—
Key dataOct 16, 2026
Open
$99.02
From 52W high
−54.46%
Volume
2.40M
Market cap
$21.02B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−26.5x
P/E (TTM)
—
RSI (14)
29.6
MomentumView details →
1D Return
−2.96%
YTD Return
−44.32%
SummaryUpdated Jun 1, 2026
Insmed Incorporated (NASDAQ:INSM) is a biopharmaceutical company founded in 1988 and headquartered in Bridgewater, New Jersey. The company has evolved from its early days to become a specialized developer and commercializer of therapies for patients with serious and rare diseases, particularly focusing on respiratory conditions. Insmed went public in 2000 and has built its business around innovative drug delivery technologies and treatments for orphan diseases with significant unmet medical needs.
Similar companies
Latest newsMore news →